Appian received a Zacks Rank #1 designation, placing it in the top 5% of covered stocks based on earnings estimate revisions and classifying it as a strong buy.

Analysts have increased Appian’s fiscal 2026 EPS consensus by 8.3% over the past three months, lifting the estimate to $0.84 per share and signaling improving profitability trends.

Upward revisions in earnings estimates are a proven driver of institutional buying, suggesting the upgrade could lead to near-term stock price gains as investors adjust valuations.